O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×

enzymes2.pptx

Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Próximos SlideShares
Enzymes
Enzymes
Carregando em…3
×

Confira estes a seguir

1 de 22 Anúncio

Mais Conteúdo rRelacionado

Semelhante a enzymes2.pptx (20)

Mais recentes (20)

Anúncio

enzymes2.pptx

  1. 1. PRINCIPLES OF ENZYME ACTIVITY
  2. 2. MECHANISMS OF ENZYME ACTION • ENZYMES ENHANCE THE RATE OR VELOCITY OF A REACTION BUT DO NOT ALTER THE EQUILIBRIUM CONSTANT • CATALYSIS IS BROUGHT ABOUT IN ONE OR MANY WAYS LOWERING OF ACTIVATION ENERGY • ACTIVATION ENERGY IS THE ENERGY REQUIRED TO RAISE THE LEVEL OF THE SUBSTRATE FROM THE GROUND TO THE TRANSITION STATE • ENZYMES REDUCE THE MAGNITUDE OF THIS ACTIVATION ENERGY Acid hydrolysis – 26,000 cal/mol SUCROSE Sucrase- 9,000 cal/mol
  3. 3. without enzyme with enzyme E time • THIS CAUSES REACTIONS TO PROCEED AT A LOWER TEMPERATURE ADVANTAGEOUS IN BIOLOGICAL SYSTEMS
  4. 4. CATALYSIS BY PROXIMITY (ENTROPY EFFECT) • ENZYMES DECREASE THE ENTROPY OF THE REACTANTS • ENAABLES THE REACTANTS TO COME CLOSER TO THE ENZYME • ENHANCES THE RATE OF ES FORMATION CATALYSIS BY STRAIN • FOLLOWS THE INDUCED FIT THEORY • SUBSTRATE IS STRAINED DUE TO THE CONFORMATIONAL CHANGE IN THE ENZYME • ENERGY LEVEL OF SUBSTRATE IS RAISED DUE TO THE STRAIN • COVALENT BONDS ARE BROKEN • Eg. LYSOZYME CLEAVES β-1,4 GLYCOSIDIC BONDS
  5. 5. ACID-BASE CATALYSIS • AMINO ACID RESIDUES AT ACTIVE SITE OF ENZYME ACT AS ACIDS/BASES i.e. DONOR OR ACCEPTOR OF H⁺/e⁻ • Acids NH₂‚ –OH‚ –SH‚ ϵ - amino groups • Bases -COO⁻ , conjugates of acidic groups • Eg. CLEAVAGE OF PHOSPHODIESTER BONDS BY RIBONUCLEASE COVALENT CATALYSIS • ENZYMES HAVE -vely CHARGED (NUCLEOPHILIC) OR +vely CHARGED (ELECTROPHILIC) GROUPS AT ACTIVE SITE • THESE GROUPS FORM TRANSIENT COVALENT BONDS WITH THE SUBSTRATE • ENZYME ITSELF BECOMES A REACTANT FOR A TRANSIENT PERIOD OF TIME • COVALENT BONDS ARE BROKEN TO FORM PRODUCTS • Eg. CLEAVAGE OF PEPTIDE BONDS BY TRYPSIN
  6. 6. FACTORS AFFECTING ENZYME ACTIVITY CONCENTRATION OF SUBSTRATE • INCREASE IN SUBSTRATE CONCENTRATION GRADUALLY INCREASES THE RATE/VELOCITY OF AN ENZYMATIC REACTION Vmax C B V ½ Vmax A km k₁ k₃ [S] E+S ES E+P k₂ k₂+ k₃ k₁ =Km
  7. 7. Vmax[S] V= (Michaelis-Menten equation) Km+ [S] If V= ½ Vmax Vmax [S] Then, ½ Vmax = Km+ [S] Km= [S] i.e. at ½ Vmax , Km=[S] Km IS DEFINED AS THE SUBSTRATE CONCENTRATION AT HALF MAXIMAL VELOCITY (moles/L)
  8. 8. SIGNIFICANCE OF Km VALUE • IT IS CONSTANT & IS THE CHARACTERISTIC FEATURE (SIGNATURE) FOR A GIVEN ENZYME • IT IS INDEPENDENT OF ENZYME CONCENTRATION • IT INDICATES THAT HALF OF ENZYME MOLECULES ARE BOUND WITH THE SUBSTRATE MOLECULES AT THAT PARTICULAR SUBSTARTE CONCENTRATION • Km DENOTES THE AFFINITY OF ANY ENZYME FOR ITS SUBSTRATE • LOW Km VALUE INDICATES A STRONG AFFINITY BETWEEN AN ENZYME & ITS SUBSTRATE WHEREAS A HIGH Km VALUE REFLECTS WEAK AFFINITY.
  9. 9. CONCENTRATION OF ENZYME V [E] • AS THE CONCENTRATION OF ENZYME IS INCREASED THE VELOCITY/RATE OF REACTION INCREASES PROPORTIONATELY (when all other factors affecting enzyme activity are kept constant) • THIS PROPERTY IS USED FOR DETERMINING THE ACTIVITY OF ENZYMES FOR DIAGNOSIS OF DISEASES
  10. 10. TEMPERATURE V optimum temperature 0 10 20 30 40 50 60 Temp • INCREASE IN TEMP. RESULTS IN AN INCREASE IN THE RATE OF RXN UPTO A CERTAIN EXTENT AFTER WHICH THE ACTIVITY DECREASES • MAXIMUM ACTIVITY IS SEEN AT THE OPTIMUM TEMPERATURE
  11. 11. pH 1 2 3 4 5 6 7 8 9 10 11 12 13 14 pH • MAXIMUM ACTIVITY OF ENZYME IS SEEN AT THE OPTIMUM pH , BELOW AND ABOVE WHICH THE ACTIVITY DECLINES • H⁺ IONS ALTER THE IONIC CHARGES ON THE AMINO ACIDS AT THE ACTIVE SITE • ALSO AFFECT THE IONISATION OF SUBSTRATE AND ES COMPLEX • DISSOCIATION OF CO-ENZYMES AT EXTREME pH • DISRUPTION OF IONIC & HYDROGEN BONDS
  12. 12. CONCENTRATION OF PRODUCTS • IN CONCENTRATION OF PRODUCT es THE RATE OF RXN • PRODUCT FORMS A LOOSE COMPLEX WITH THE ENZYME AT THE ACTIVE SITE & PREVENTS THE BINDING OF SUBSTRATE, THUS DECREASINGS THE ACTIVITY OF ENZYME • END PRODUCT INHIBITION IN BIOLOGICAL SYSTEMS IS IMPORTANT FOR REGULATION OF METABOLIC PATHWAYS E₁ E₂ E₃ A B C D -
  13. 13. ACTIVATORS & INHIBITORS • PRESENCE OF IONS (Mg²⁺, Mn²⁺, Zn²⁺,Ce⁻) es THE ACTIVITY OF CERTAIN ENZYMES • PRESENCE OF INHIBITIORS es THE ACTIVITY • IONS COMBINE WITH SUBSTRATE, FORM METAL-ES COMPLEX, PARTICIPATE DIRECTLY IN RXNS, CHANGE CONFORMATION OF ENZYME, INHIBIT SUBSTRATE BINDING
  14. 14. ENZYME INHIBITION
  15. 15. ENZYME INHIBITION ENZYME INHIBITORS ARE MOLECULAR AGENTS THAT INTERFERE WITH CATALYSIS (SLOW DOWN OR HALT REACTIONS) AND REDUCE THE RATE OF REACTION Eg. ASPIRIN – Pharmaceutical agent TYPES OF INHIBITION REVERSIBLE COMPETITIVE NON-COMPETITIVE MIXED UN-COMPETITIVE IRREVERSIBLE
  16. 16. REVERSIBLE INHIBITION ACTIVITY OF ENZYME IS RESTORED FULLY WHEN THE INHIBITOR IS REMOVED FROM THE SYSTEM E + I EI Ki inhibition constant Competitive inhibition  Inhibitor competes with substrate  ″ is a structural analog of substrate  ″ binds to the enzyme at SBS  Both ES & EI complex formed  IF [S] >> [I] normal Vmax  IF [S] << [I] [ES] Vmax  MORE OF SUBSTRATE IS NEEDED TO FORM ES APPARENT in Km
  17. 17. Non-Competitive inhibition  NO COMPETITION BETWEEN ʽSʼ & ʽIʼ  STRUCTURALLY DIFFERENT  ʽIʼ BINDS TO A SITE OTHER THAN SBS  EI AND ESI COMPLEX IS FORMED  AFFINITY OF ʽSʼ FOR ʽEʼ UNALTERED  Km REMAINS SAME  ESI COMPLEX BREAKDOWN IS SLOWED  REACTION IS SLOWED Vmax
  18. 18. Un-competitive inhibition  RARE , ONLY SEEN IN BISUBSTRATE RxNS.  ʽΙʼ BINDS TO ES COMPLEX  ʽIʼ HAS NO AFFINITY FOR FREE ENZYME  ʽESIʼ COMPLEX FORMED  Km apparent (as [S] required to reach ½ Vmax decreases by factor ά )
  19. 19. Mixed inhibition  ʽESʼ, ‘EI’ & ʽΕSΙʼ FORMED  BOTH Km & Vmax ALTERED ( Km; Vmax)  USUALLY SEEN IN BI-SUBSTRATE RxNS.
  20. 20. INHIBITION Vmax Km Competitive same Non-competitive same Un-competitive Mixed
  21. 21. IRREVERSIBLE INHIBITION  ‘I’ BINDS COVALENTLY TO ʽEʼ  NO COMPETITION BETWEEN ʽIʼ & ʽSʼ  DESTRUCTION OF FUNCTIONAL GROUP AT ACTIVE SITE ESSENTIAL FOR ACTIVITY  NOT REVERSED BY REMOVING ʽIʼ OR INCREASING [S]  KINETICS IS SIMILAR TO REV. NON-COMPETITIVE INHIBITION  SUICIDE INHIBITION  SPECIAL TYPE OF IRREVERSIBLE INHIBITION  ʽIʼ BINDS TO SBS UNDERGOES CATALYSIS PRODUCT FORMED IS IRREVERSIBLE INHIBITOR BINDS COVALENTLY & DESTROYS ʽEʼ
  22. 22. APPLICATIONS OF ENZYME INHIBITION Inhibitor Enzyme Use Allopurinol Xanthine oxidase Gout Methotrexate DHF reductase Cancer Succinylcholine Ach esterase Muscle relaxant Lovastatin HMG CoA reductase Atherosclerosis

×